DOI
https://doi.org/10.18849/ve.v1i4.83Abstract
Various anti-epileptic drugs (AEDs) are used for the management of idiopathic epilepsy (IE) in dogs. Their safety profile is an important consideration for regulatory bodies, owners and prescribing clinicians. However, information on their adverse effects still remains limited with most of it derived from non-blinded non-randomized uncontrolled trials and case reports.
This poster won third place, which was presented at the Veterinary Evidence Today conference, Edinburgh November 1-3, 2016.
References
NA
License
Veterinary Evidence uses the Creative Commons copyright Creative Commons Attribution 4.0 International License. That means users are free to copy and redistribute the material in any medium or format. Remix, transform, and build upon the material for any purpose, even commercially - with the appropriate citation.
Most read articles by the same author(s)
- Marios Charalambous, David Brodbelt, Holger Andreas Volk, The Evidence Behind the Treatment of Canine Idiopathic Epilepsy , Veterinary Evidence: Vol. 1 No. 1 (2016): The inaugural issue
- Marios Charalambous, Sergio A. Gomes, Stella Papageorgiou, Massimo Orioles, Epileptic Seizures Versus Syncope: Pathophysiology and Clinical Approach , Veterinary Evidence: Vol. 2 No. 1 (2017): The first issue of 2017
- Marios Charalambous, David Brodbelt, Holger Andreas Volk, The Evidence Behind the Diagnostic Investigation of Canine Idiopathic Epilepsy , Veterinary Evidence: Vol. 1 No. 1 (2016): The inaugural issue
- Marios Charalambous, Surgery in Epilepsy – How Advances in Human Neurology Can Benefit Veterinary Patients , Veterinary Evidence: Vol. 1 No. 1 (2016): The inaugural issue
